In an effort to keep artemisinin resistance at bay, the World Health Organization (WHO) has
recommended artemisinin combination therapies (ACTs)-- uniting artemisinin derivatives with bygone antimalarial drugs — as the preferred front - line treatment.
Not exact matches
Currently,
artemisinin - based
combination therapy (ACT) is
recommended by the WHO to treat uncomplicated malaria.
Dihydroartemisinin - piperaquine is one of five
artemisinin - based
combination therapies currently
recommended by the World Health Organization (WHO), and this review finds that it is also one of the most studied.